Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Citi
McKesson
Moodys
Argus Health
AstraZeneca
Medtronic
Farmers Insurance

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206743

« Back to Dashboard

NDA 206743 describes DARIFENACIN HYDROBROMIDE, which is a drug marketed by Alembic Pharms Ltd, Anchen Pharms, Aurobindo Pharma Ltd, Cipla Ltd, Jubilant Generics, and Torrent Pharms Ltd, and is included in six NDAs. It is available from nine suppliers. Additional details are available on the DARIFENACIN HYDROBROMIDE profile page.

The generic ingredient in DARIFENACIN HYDROBROMIDE is darifenacin hydrobromide. There are nineteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the darifenacin hydrobromide profile page.
Summary for 206743
Tradename:DARIFENACIN HYDROBROMIDE
Applicant:Aurobindo Pharma Ltd
Ingredient:darifenacin hydrobromide
Patents:0
Therapeutic Class:Genitourinary Agents
Pharmacology for NDA: 206743
Suppliers and Packaging for NDA: 206743
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DARIFENACIN HYDROBROMIDE darifenacin hydrobromide TABLET, EXTENDED RELEASE;ORAL 206743 ANDA Aurobindo Pharma Limited 65862-861 N 65862-861-05
DARIFENACIN HYDROBROMIDE darifenacin hydrobromide TABLET, EXTENDED RELEASE;ORAL 206743 ANDA Aurobindo Pharma Limited 65862-861 N 65862-861-90

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 7.5MG BASE
Approval Date:Sep 19, 2016TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 15MG BASE
Approval Date:Sep 19, 2016TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Cerilliant
Dow
Colorcon
Julphar
Deloitte
Express Scripts
Queensland Health
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.